Investigating Patient Satisfaction With Oral Anti-Cancer Treatment. Prospective Non-interventional Non-controlled Multicenter Observational Study to Evaluate Aspects of Pharmaceutical Care in Patients With Advanced Renal Cell Carcinoma Treated With an Oral Anti-cancer Drug.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- KU Leuven
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- Medication adherence
研究概览
简要总结
Prospective non-interventional non-controlled multicenter observational study to evaluate aspects of pharmaceutical care in patients with advanced renal cell carcinoma treated with an oral anti-cancer drug.
The main objective of this study is to evaluate the patient perspective in the treatment of advanced renal cell carcinoma with an oral anti-cancer drug.
The following aspects will be investigated:
- Intrinsic desire for information about treatment.
- Patient satisfaction with treatment information.
- Patient satisfaction with treatment.
- Medication adherence.
- Health-related quality of life.
- The role of different health care professionals in the treatment of RCC with oral drugs
This study should reveal information necessary for the development of pharmacotherapeutic care concepts that meet the needs of cancer patients treated with an oral anti-cancer drug over a long period.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who are 18 years or older, and who can be contacted by phone and/or e-mail are eligible for the study
排除标准
- •Patients who are not able to understand Dutch or French will be excluded from the study
结局指标
主要结局
Medication adherence
时间窗: one year
At the first visit patients will receive their anti-cancer medication by the hospital in a pill box which electronically records openings cf. Medication Event Monitoring System (MEMS®, Aardex). The recorded information in this chip will be read in the hospital pharmacy each time the patient gets new capsules. This information is strictly confidential and can only be consulted by the research team at the KULeuven.
次要结局
- Cancer Therapy Satisfaction Questionnaire (CTSQ)(one year)
- Extent of Information Desire (EID)(one year)
- Morisky Medication Adherence Scale (MMAS)(one year)
- Patient Satisfaction with Cancer Treatment Education (Ps-CaTE)(one year)
- Functional Assessment of Cancer Therapy - General (FACT-G)(one year)
- Functional Kidney Symptom Index (FKSI)(one year)
- Satisfaction With Pharmacist (SwiP)(one year)